https://org27569agonist.com/me....dical-outcomes-of-op
However, these molecular analyses are generally done utilizing tissue obtained via biopsy, involving significant danger and is often not feasible. In addition, biopsied tissue doesn't constantly reflect tumour heterogeneity, and sequential biopsies to track disease progression (eg, introduction of drug opposition mutations) aren't well accepted. To conquer these along with other biopsy-associated limits, we have created non-invasive 'liquid biopsy' technologies to allow the molecu
Like
Comment
Share
